A Case of Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome with Dissociated Pathological and Immunological Findings

<div>Disease course after admission. The patient was suspected of SLE/AAV OS with serological features of SLE, and the treatment was changed to PSL monotherapy on day 8. Thereafter, the dosage of PSL was gradually decreased, and serum creatinine levels improved from a maximum of 7.06 mg/dL to 3.39 mg/dL on day 56.</div>

Case Reports in Nephrology

fig1

Figure 1

Figure 1: A Case of Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome with Dissociated Pathological and Immunological Findings 

Figure 1 | A Case of Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome with Dissociated Pathological and Immunological Findings 